Arjun Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arjun Kumar has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Balbir Singh
Department of Microbiology, Maharishi Markandeshwar Medical College and Hospital, Solan, India
5 shared publications- Mayank Mishra
Pulmonary Medicine, All India Institute of Medical Sciences Rishikesh, Rishikesh, Uttarakhand, India
4 shared publications Rohit Manchanda
Department of Respiratory Medicine, Maharishi Markandeshwar Medical College and Hospital, Solan, India
4 shared publicationsAshok Kumar Janmeja
Department of Respiratory Medicine, Maharishi Markandeshwar Medical College and Hospital, Solan, India
3 shared publicationsGirish Sindhwani
Department of Pulmonary Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand
3 shared publicationsRahul Gupta
Department of Respiratory Medicine, Maharishi Markandeshwar Medical College and Hospital, Solan, India
3 shared publications
Latest Publications
- Open Access
- 21 April 2026
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
Clinical outcomes of rigid bronchoscopic airway interventions: insights from an Indian tertiary care center
Rigid bronchoscopy (RB) forms an indispensable part of the interventional bronchoscopist’s skills, allowing the performance of complex airway interventions for a variety of benign and malignant airway disorders. Experiential data on the procedure is limited, particularly in adults. We conducted a retrospective analysis of medical records from 82 adult patients who underwent RB at our center. The primary objective was to evaluate the clinical indications, procedural outcomes, complication rates, and overall efficacy of RB in this cohort. Collected data included patient demographics, presenting symptoms, etiological diagnoses, and anesthesia-related parameters such as induction agents, maintenance protocols, sedation strategies, and the use of neuromuscular blockade. Post-procedural outcomes and follow-up mortality were also assessed. The mean patient age was 56.2±12.6 years, with 71.9% males. Common symptoms were cough (90.2%) and dyspnea (82.9%). Malignancies accounted for 90.2% of cases, with lung cancer being the most prevalent (68.2%). RB was primarily performed for stenting (63.4%) and tumor debulking (29.2%). Total intravenous anesthesia was used in 92.6%, with mean induction and reversal times of 75.3±4.3 seconds and 10.69±2.4 minutes, respectively. Minor complications occurred in 29.3% (bleeding 29.3%, bronchospasm 17.1%, and hypoxia 13.4%) and major complications in 2.4%. After the procedure, immediate extubation was achieved in 49 patients (59.8%), while 24 (29.3%) required short-term ventilator support (24 h). The median hospital stay was 7 days (interquartile range 5-11). Symptomatic improvement at discharge was observed in 72/82 patients (87.8%). In-hospital mortality was 6.1% (5/82), mainly due to severe infections (hospital-acquired or ventilator-associated pneumonia) or massive endobronchial bleeding. Among patients with available follow-up (n=52), 3-month mortality was 11.5% (n=6). In this real-world cohort, RB demonstrated a high success rate with minimal complications, reinforcing its role as a critical tool in managing complex airway conditions. The procedure demonstrated high efficacy, particularly in malignant cases, with acceptable complication rates. Dedicated training is essential to enhance experience, gain expertise, and ensure optimal outcomes while minimizing procedural risks.
- 21 April 2026
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
Open AccessClinical outcomes of rigid bronchoscopic airway interventions: insights from an Indian tertiary care center
Rigid bronchoscopy (RB) forms an indispensable part of the interventional bronchoscopist’s skills, allowing the performance of complex airway interventions for a variety of benign and malignant airway disorders. Experiential data on the procedure is limited, particularly in adults. We conducted a retrospective analysis of medical records from 82 adult patients who underwent RB at our center. The primary objective was to evaluate the clinical indications, procedural outcomes, complication rates, and overall efficacy of RB in this cohort. Collected data included patient demographics, presenting symptoms, etiological diagnoses, and anesthesia-related parameters such as induction agents, maintenance protocols, sedation strategies, and the use of neuromuscular blockade. Post-procedural outcomes and follow-up mortality were also assessed. The mean patient age was 56.2±12.6 years, with 71.9% males. Common symptoms were cough (90.2%) and dyspnea (82.9%). Malignancies accounted for 90.2% of cases, with lung cancer being the most prevalent (68.2%). RB was primarily performed for stenting (63.4%) and tumor debulking (29.2%). Total intravenous anesthesia was used in 92.6%, with mean induction and reversal times of 75.3±4.3 seconds and 10.69±2.4 minutes, respectively. Minor complications occurred in 29.3% (bleeding 29.3%, bronchospasm 17.1%, and hypoxia 13.4%) and major complications in 2.4%. After the procedure, immediate extubation was achieved in 49 patients (59.8%), while 24 (29.3%) required short-term ventilator support (24 h). The median hospital stay was 7 days (interquartile range 5-11). Symptomatic improvement at discharge was observed in 72/82 patients (87.8%). In-hospital mortality was 6.1% (5/82), mainly due to severe infections (hospital-acquired or ventilator-associated pneumonia) or massive endobronchial bleeding. Among patients with available follow-up (n=52), 3-month mortality was 11.5% (n=6). In this real-world cohort, RB demonstrated a high success rate with minimal complications, reinforcing its role as a critical tool in managing complex airway conditions. The procedure demonstrated high efficacy, particularly in malignant cases, with acceptable complication rates. Dedicated training is essential to enhance experience, gain expertise, and ensure optimal outcomes while minimizing procedural risks.
- Open Access
- 9 October 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19  (1) , 1-6
A prospective descriptive study to assess practice regarding referral for smoking cessation counseling by health care workers
Background: Tobacco use is a leading cause of preventable deaths worldwide. Despite national and institutional policies, referral to smoking cessation counseling by healthcare workers in India remains limited. We planned a study to assess the practice of referral for smoking cessation counseling by healthcare workers. Methods: A prospective descriptive study was conducted from January to May 2024. A total of 1832 patients were screened for smoking status; 612 (33.4%) were active smokers and 122 (6.6%) were former smokers. Active smokers admitted to the respiratory medicine ward were interviewed regarding smoking cessation referrals. In parallel, 290 healthcare workers (doctors, nurses, and interns) were surveyed using a validated 21-item semi-structured questionnaire. Data were analyzed using SPSS v28.0.1.0 for descriptive statistics and associations. Results: Among active smokers, only 265 (43.3%) received cessation counseling. Of 290 healthcare workers, 37 (12.7%) had formal training in smoking cessation counseling. Lack of training and lower education were significantly associated with reduced counseling practices (p = 0.0015 and p = 0.0453). Most healthcare workers (63.7%) rarely assessed nicotine dependence, and 42.3% rarely evaluated readiness to quit. Conclusion: Referral for smoking cessation remains inadequate. Regular training, motivation, and accountability measures are essential to improve healthcare workers’ role in tobacco control.
- 9 October 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19  (1) , 1-6
Open AccessA prospective descriptive study to assess practice regarding referral for smoking cessation counseling by health care workers
Background: Tobacco use is a leading cause of preventable deaths worldwide. Despite national and institutional policies, referral to smoking cessation counseling by healthcare workers in India remains limited. We planned a study to assess the practice of referral for smoking cessation counseling by healthcare workers. Methods: A prospective descriptive study was conducted from January to May 2024. A total of 1832 patients were screened for smoking status; 612 (33.4%) were active smokers and 122 (6.6%) were former smokers. Active smokers admitted to the respiratory medicine ward were interviewed regarding smoking cessation referrals. In parallel, 290 healthcare workers (doctors, nurses, and interns) were surveyed using a validated 21-item semi-structured questionnaire. Data were analyzed using SPSS v28.0.1.0 for descriptive statistics and associations. Results: Among active smokers, only 265 (43.3%) received cessation counseling. Of 290 healthcare workers, 37 (12.7%) had formal training in smoking cessation counseling. Lack of training and lower education were significantly associated with reduced counseling practices (p = 0.0015 and p = 0.0453). Most healthcare workers (63.7%) rarely assessed nicotine dependence, and 42.3% rarely evaluated readiness to quit. Conclusion: Referral for smoking cessation remains inadequate. Regular training, motivation, and accountability measures are essential to improve healthcare workers’ role in tobacco control.
- Open Access
- 4 October 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19  (1) , 1-6
Diffuse alveolar hemorrhage secondary to antiplatelet therapy: a rare complication
Introduction: Diffuse alveolar hemorrhage (DAH) is a life-threatening condition that can quickly lead to respiratory failure. Its occurrence due to antiplatelet therapy is rare, particularly during acute coronary syndrome (ACS) treatment. This report presents a notable case of DAH in a 74-year-old man following antiplatelet use after percutaneous coronary angioplasty. Case discussion: A 74-year-old male with a history of hypertension and heavy smoking presented with shortness of breath and chest pain, later diagnosed with ST-elevation myocardial infarction (STEMI). He underwent successful PCI with stenting of the left circumflex artery. Post-procedure, he developed hemoptysis and respiratory distress; imaging and bronchoalveolar lavage indicated diffuse alveolar hemorrhage (DAH), suspected to be caused by antiplatelet therapy. Ticagrelor was discontinued and corticosteroids initiated, leading to gradual improvement. The patient recovered well and was discharged, remaining stable on follow-up 8 months later. Conclusion: Diffuse alveolar hemorrhage (DAH) is a life-threatening emergency that can resemble acute pulmonary edema, making early suspicion and diagnosis essential for proper treatment.
- 4 October 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19  (1) , 1-6
Open AccessDiffuse alveolar hemorrhage secondary to antiplatelet therapy: a rare complication
Introduction: Diffuse alveolar hemorrhage (DAH) is a life-threatening condition that can quickly lead to respiratory failure. Its occurrence due to antiplatelet therapy is rare, particularly during acute coronary syndrome (ACS) treatment. This report presents a notable case of DAH in a 74-year-old man following antiplatelet use after percutaneous coronary angioplasty. Case discussion: A 74-year-old male with a history of hypertension and heavy smoking presented with shortness of breath and chest pain, later diagnosed with ST-elevation myocardial infarction (STEMI). He underwent successful PCI with stenting of the left circumflex artery. Post-procedure, he developed hemoptysis and respiratory distress; imaging and bronchoalveolar lavage indicated diffuse alveolar hemorrhage (DAH), suspected to be caused by antiplatelet therapy. Ticagrelor was discontinued and corticosteroids initiated, leading to gradual improvement. The patient recovered well and was discharged, remaining stable on follow-up 8 months later. Conclusion: Diffuse alveolar hemorrhage (DAH) is a life-threatening emergency that can resemble acute pulmonary edema, making early suspicion and diagnosis essential for proper treatment.
- Open Access
- 3 February 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19  (1) , 1-7
Role of CBNAAT in the diagnosis of extrapulmonary tuberculosis: a prospective cross-sectional study
Background: Tubercular lymphadenitis (TBLN) is the most common extrapulmonary tuberculosis (EPTB) followed by tubercular pleural effusion (TPE). The bacteriological confirmation to diagnose EPTB is more difficult due to its paucibacillary nature often leading to delay or misdiagnosis. The role of the CBNAAT test for the diagnosis of EPTB is highly variable among different populations. Hence, the aim of the present study was to evaluate the role of CBNAAT in the diagnosis of EPTB in a tertiary care center in north India. Methods: This was a cross-sectional study conducted in the 100 stable patients of EPTB (55 TPE and 45 TBLN) who came to the Respiratory Medicine Department in MMMC&H, Solan, India. The total duration of the study was eighteen months from April 2021 to September 2022. Fine needle aspirate and pleural fluid samples were collected from all suspected TPE and TBLN patients respectively and were subjected to CBNAAT investigation. All other recommended investigations used for diagnosis of TBLN and TPE were also performed including ZN stain, FNAC, biochemical analysis of pleural fluid, Mantoux test, radiological imaging, and other routine investigations. The data analysis was done using SPSS version 20 software. Results: Out of 100 patients of EPTB, 55 were TPE, and 45 were TBLN patients. The positivity of CBNAAT was higher in TBLN patients (57.8%) as compared to TPE (23.7%) patients. The correlation between CBNAAT and ZN stain was statistically significant in both TBLN (p = 0.008) and TPE (p = 0.001) patients. The correlation of CBNAAT with FNAC, duration of illness, erythrocyte sedimentation rate (ESR), and Mantoux were all statistically significant (p < 0.05). Conclusion: Our study finding showed higher positivity of CBNAAT in the TBLN as compared to that in patients of TPE. The positivity of CBNAAT in the TBLN patients was higher in pus and cheesy FNAC samples, Mantoux-positive patients, and those with high ESR value.
- 3 February 2025
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 19  (1) , 1-7
Open AccessRole of CBNAAT in the diagnosis of extrapulmonary tuberculosis: a prospective cross-sectional study
Background: Tubercular lymphadenitis (TBLN) is the most common extrapulmonary tuberculosis (EPTB) followed by tubercular pleural effusion (TPE). The bacteriological confirmation to diagnose EPTB is more difficult due to its paucibacillary nature often leading to delay or misdiagnosis. The role of the CBNAAT test for the diagnosis of EPTB is highly variable among different populations. Hence, the aim of the present study was to evaluate the role of CBNAAT in the diagnosis of EPTB in a tertiary care center in north India. Methods: This was a cross-sectional study conducted in the 100 stable patients of EPTB (55 TPE and 45 TBLN) who came to the Respiratory Medicine Department in MMMC&H, Solan, India. The total duration of the study was eighteen months from April 2021 to September 2022. Fine needle aspirate and pleural fluid samples were collected from all suspected TPE and TBLN patients respectively and were subjected to CBNAAT investigation. All other recommended investigations used for diagnosis of TBLN and TPE were also performed including ZN stain, FNAC, biochemical analysis of pleural fluid, Mantoux test, radiological imaging, and other routine investigations. The data analysis was done using SPSS version 20 software. Results: Out of 100 patients of EPTB, 55 were TPE, and 45 were TBLN patients. The positivity of CBNAAT was higher in TBLN patients (57.8%) as compared to TPE (23.7%) patients. The correlation between CBNAAT and ZN stain was statistically significant in both TBLN (p = 0.008) and TPE (p = 0.001) patients. The correlation of CBNAAT with FNAC, duration of illness, erythrocyte sedimentation rate (ESR), and Mantoux were all statistically significant (p < 0.05). Conclusion: Our study finding showed higher positivity of CBNAAT in the TBLN as compared to that in patients of TPE. The positivity of CBNAAT in the TBLN patients was higher in pus and cheesy FNAC samples, Mantoux-positive patients, and those with high ESR value.
- Open Access
- 21 July 2024
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 95  (2)
Proportion of sleep-related breathing disorders and their association with echocardiographic parameters in stable patients with chronic obstructive pulmonary disease: a cross-sectional observational exploratory study
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality throughout the world. The coexistence of COPD and obstructive sleep apnea (OSA) (i.e., overlap syndrome) has been reported in several studies. Both disorders independently increase the risk of cardiovascular complications. Hence, there is a theoretical possibility that cardiovascular parameters may be worse in patients with overlap syndrome compared to those with only COPD. However, this has been sparsely assessed in the literature. This study aimed to compare the clinical characteristics, echocardiography, and sleep parameters amongst COPD patients with and without sleep-related breathing disorders (SRBD). This observational, cross-sectional study included 30 patients with stable COPD. All participants underwent a detailed clinical evaluation, followed by level 1 polysomnography (PSG). Each participant underwent echocardiographic evaluation to estimate mean pulmonary artery pressure from right ventricular systolic pressure (RVSP). Based on their PSG findings, participants were classified into non-SRBD and SRBD groups. Both groups were further compared with respect to clinical characteristics, echocardiographic, and PSG parameters. We found that most of the participants (93.3%) were male, and the mean age of the study population was 56±8.2 years. The only SRBD identified in this study was OSA, which was observed in 80% of participants. In this group, OSA was not associated with obesity. Systemic hypertension (50%) was the most common comorbidity, followed by diabetes mellitus (26.67%), but neither was significantly different between the groups. The mean RVSP was significantly higher among OSA patients than non-OSA patients (41.25±14.98 vs. 30.83±5.84, respectively; p=0.01). OSA was seen in 80% of participants with stable COPD, even in the absence of obesity. The presence of OSA was associated with a higher RVSP in this patient group.
- 21 July 2024
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 95  (2)
Open AccessProportion of sleep-related breathing disorders and their association with echocardiographic parameters in stable patients with chronic obstructive pulmonary disease: a cross-sectional observational exploratory study
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality throughout the world. The coexistence of COPD and obstructive sleep apnea (OSA) (i.e., overlap syndrome) has been reported in several studies. Both disorders independently increase the risk of cardiovascular complications. Hence, there is a theoretical possibility that cardiovascular parameters may be worse in patients with overlap syndrome compared to those with only COPD. However, this has been sparsely assessed in the literature. This study aimed to compare the clinical characteristics, echocardiography, and sleep parameters amongst COPD patients with and without sleep-related breathing disorders (SRBD). This observational, cross-sectional study included 30 patients with stable COPD. All participants underwent a detailed clinical evaluation, followed by level 1 polysomnography (PSG). Each participant underwent echocardiographic evaluation to estimate mean pulmonary artery pressure from right ventricular systolic pressure (RVSP). Based on their PSG findings, participants were classified into non-SRBD and SRBD groups. Both groups were further compared with respect to clinical characteristics, echocardiographic, and PSG parameters. We found that most of the participants (93.3%) were male, and the mean age of the study population was 56±8.2 years. The only SRBD identified in this study was OSA, which was observed in 80% of participants. In this group, OSA was not associated with obesity. Systemic hypertension (50%) was the most common comorbidity, followed by diabetes mellitus (26.67%), but neither was significantly different between the groups. The mean RVSP was significantly higher among OSA patients than non-OSA patients (41.25±14.98 vs. 30.83±5.84, respectively; p=0.01). OSA was seen in 80% of participants with stable COPD, even in the absence of obesity. The presence of OSA was associated with a higher RVSP in this patient group.
- 18 June 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Respiratory Care
- Vol. 13  (2) , 91-94
Understanding Awareness of Patient Rights: A Cross-sectional Survey among Healthcare Workers, Patients, and Attendees
- 18 June 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Respiratory Care
- Vol. 13  (2) , 91-94
Understanding Awareness of Patient Rights: A Cross-sectional Survey among Healthcare Workers, Patients, and Attendees
- 6 April 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Respiratory Care
- Vol. 13  (1) , 10-14
Basic Working Knowledge of Pulse Oximetry among Healthcare Workers and Patients Requiring Oxygen Therapy in a Tertiary Care Center in North India
- 6 April 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Respiratory Care
- Vol. 13  (1) , 10-14
Basic Working Knowledge of Pulse Oximetry among Healthcare Workers and Patients Requiring Oxygen Therapy in a Tertiary Care Center in North India
- Open Access
- 1 March 2024
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
A study to assess the relationship between vitamin D3 levels and the risk of acute exacerbation in patients with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is one of the top three causes of mortality worldwide. Vitamin D deficiency in COPD has been associated with poor lung function and decreased muscle power, which further increases the risk of exacerbations. The role of vitamin D in preventing acute exacerbations of COPD has conflicting results in the literature. Hence, we planned this study to assess the relationship between vitamin D3 levels and the risk of acute exacerbations among COPD patients in a tertiary care center in north India. This was a prospective randomized control trial that was performed on 100 consecutive stable COPD patients attending the Department of Respiratory Medicine at Maharishi Markandeshwar Medical College and Hospital, Solan, India. The patients with subnormal vitamin D3 levels (i.e., less than 30 ng/mL) were divided into the intervention and control groups. Baseline demographic profiles, lung function, COPD assessment test (CAT) score, modified Medical Research Council grade and chest radiology were performed and repeated after 12 months in all these patients. All these parameters were recorded and compared with the baseline values obtained at the beginning of the study. Out of 100 subjects, 96 had vitamin D deficiency, of which 48 were assigned to the intervention group and 48 to the control group. Among the 100 subjects, 74 (74%) were males and 26 (26%) were females, with a mean age of 66.9±9.4 years. The mean vitamin D level was 14.71±6.69 in these 96 patients. The vitamin D level improved after 3 months of supplementation to the mean level of 45.56±16.18 in the intervention group. Vitamin D supplementation was positively correlated with a decrease in the rate of acute exacerbations in the intervention group in terms of reduction in mean CAT score (4.17 in intervention and 1.43 in non-interventional group, p<0.001), number of acute exacerbations (1.7 in intervention and -1.05 in non-interventional group, p<0.001), and number of emergency visits (p=0.0121) during the 9-month period after attainment of a normal vitamin D level. Vitamin D supplementation plays a key role in COPD patients with D3 hypovitaminosis in decreasing COPD acute exacerbations, improving the CAT score, and reducing the number of emergency visits.
- 1 March 2024
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
Open AccessA study to assess the relationship between vitamin D3 levels and the risk of acute exacerbation in patients with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is one of the top three causes of mortality worldwide. Vitamin D deficiency in COPD has been associated with poor lung function and decreased muscle power, which further increases the risk of exacerbations. The role of vitamin D in preventing acute exacerbations of COPD has conflicting results in the literature. Hence, we planned this study to assess the relationship between vitamin D3 levels and the risk of acute exacerbations among COPD patients in a tertiary care center in north India. This was a prospective randomized control trial that was performed on 100 consecutive stable COPD patients attending the Department of Respiratory Medicine at Maharishi Markandeshwar Medical College and Hospital, Solan, India. The patients with subnormal vitamin D3 levels (i.e., less than 30 ng/mL) were divided into the intervention and control groups. Baseline demographic profiles, lung function, COPD assessment test (CAT) score, modified Medical Research Council grade and chest radiology were performed and repeated after 12 months in all these patients. All these parameters were recorded and compared with the baseline values obtained at the beginning of the study. Out of 100 subjects, 96 had vitamin D deficiency, of which 48 were assigned to the intervention group and 48 to the control group. Among the 100 subjects, 74 (74%) were males and 26 (26%) were females, with a mean age of 66.9±9.4 years. The mean vitamin D level was 14.71±6.69 in these 96 patients. The vitamin D level improved after 3 months of supplementation to the mean level of 45.56±16.18 in the intervention group. Vitamin D supplementation was positively correlated with a decrease in the rate of acute exacerbations in the intervention group in terms of reduction in mean CAT score (4.17 in intervention and 1.43 in non-interventional group, p<0.001), number of acute exacerbations (1.7 in intervention and -1.05 in non-interventional group, p<0.001), and number of emergency visits (p=0.0121) during the 9-month period after attainment of a normal vitamin D level. Vitamin D supplementation plays a key role in COPD patients with D3 hypovitaminosis in decreasing COPD acute exacerbations, improving the CAT score, and reducing the number of emergency visits.
- 1 March 2024
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 18  (3) , OC1-OC5
Predictors of Response to Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Prospective Cohort Study
Introduction: Lung cancer carries the highest cancer-related mortality rates worldwide. Despite all recent advances, the mortality from lung cancer is still rising. A better understanding of the risk factors may help us predict responses to chemotherapy for better management. Aim: To evaluate predictors of response to chemotherapy in advanced Non-Small Cell Lung Cancer (NSCLC) patients. Materials and Methods: This was a prospective cohort study conducted in the Department of Pulmonary Medicine at Government Medical College and Hospital, Chandigarh, India. A total of 60 confirmed cases of advanced (stage IIIB and IV) NSCLC patients were enrolled consecutively for a duration of two years. Baseline clinical parameters, routine blood tests, spirometry, exercise capacity using the 6 Minute Walk Test Distance (6MWTD), and Computed Tomography (CT)-based tumour size were recorded. Certain pre-defined patient, disease, and therapy-related factors (age, gender, dyspnoea, baseline blood tests, tumour size, histology, etc.) were evaluated for their possible role as predictors of treatment response in advanced NSCLC patients. A positive response was defined if the response to chemotherapy was Complete Response (CR) or Partial Response (PR), and a negative response if the response was Progressive Disease (PD) or Stable Disease (SD) as per revised RECIST (Response evaluation criteria in solid tumors) 1.1 criteria. Variables between the two groups were compared using the Mann-Whitney U test and Chi-square test. To find out the factors that may predict response to treatment, univariate and multivariate logistic regression analysis were used. Results: Out of a total of 60 confirmed cases of NSCLC patients, only 40 patients were able to complete the four cycles of chemotherapy. The mean age of the patients was 58.5±9.6 years. There were a total of 35 males (87.5%) and five females (12.5%) in the study. Out of 40 patients, 27 (67.5%) had squamous cell carcinoma and 13 (32.5%) had adenocarcinoma. On univariate analysis, Neutrophil-Lymphocyte Ratio (NLR) had a statistically significant association with tumour response (p3.81) NLR (p=0.002) were found as independent predictors of poor response to chemotherapy. Conclusion: Pre-treatment high NLR and advanced age are significant factors for a poor response to chemotherapy treatment in advanced NSCLC patients.
- 1 March 2024
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 18  (3) , OC1-OC5
Predictors of Response to Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Prospective Cohort Study
Introduction: Lung cancer carries the highest cancer-related mortality rates worldwide. Despite all recent advances, the mortality from lung cancer is still rising. A better understanding of the risk factors may help us predict responses to chemotherapy for better management. Aim: To evaluate predictors of response to chemotherapy in advanced Non-Small Cell Lung Cancer (NSCLC) patients. Materials and Methods: This was a prospective cohort study conducted in the Department of Pulmonary Medicine at Government Medical College and Hospital, Chandigarh, India. A total of 60 confirmed cases of advanced (stage IIIB and IV) NSCLC patients were enrolled consecutively for a duration of two years. Baseline clinical parameters, routine blood tests, spirometry, exercise capacity using the 6 Minute Walk Test Distance (6MWTD), and Computed Tomography (CT)-based tumour size were recorded. Certain pre-defined patient, disease, and therapy-related factors (age, gender, dyspnoea, baseline blood tests, tumour size, histology, etc.) were evaluated for their possible role as predictors of treatment response in advanced NSCLC patients. A positive response was defined if the response to chemotherapy was Complete Response (CR) or Partial Response (PR), and a negative response if the response was Progressive Disease (PD) or Stable Disease (SD) as per revised RECIST (Response evaluation criteria in solid tumors) 1.1 criteria. Variables between the two groups were compared using the Mann-Whitney U test and Chi-square test. To find out the factors that may predict response to treatment, univariate and multivariate logistic regression analysis were used. Results: Out of a total of 60 confirmed cases of NSCLC patients, only 40 patients were able to complete the four cycles of chemotherapy. The mean age of the patients was 58.5±9.6 years. There were a total of 35 males (87.5%) and five females (12.5%) in the study. Out of 40 patients, 27 (67.5%) had squamous cell carcinoma and 13 (32.5%) had adenocarcinoma. On univariate analysis, Neutrophil-Lymphocyte Ratio (NLR) had a statistically significant association with tumour response (p3.81) NLR (p=0.002) were found as independent predictors of poor response to chemotherapy. Conclusion: Pre-treatment high NLR and advanced age are significant factors for a poor response to chemotherapy treatment in advanced NSCLC patients.
- Open Access
- 30 November 2023
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 10  (12) , 4712-4717
A descriptive study to assess the knowledge and practices related to cough and sneeze etiquette among health care providers, respiratory patients and their attendants in a tertiary care centre
Background: The emergence of respiratory infections including Tuberculosis, COVID-19, influenza A and B viruses have a significant impact on health worldwide. Cough and sneezing etiquette including respiratory hygiene have been recommended as most cost-effective preventative tool to reduce such transmission. Methods: A cross-sectional descriptive study was conducted among health care providers, respiratory patients and their attendants admitted in the Respiratory Medicine department at a tertiary care hospital for 6 months duration i.e., from December 2022 to May 2023, aiming to assess the knowledge and practices related to cough and sneeze etiquette. A total of 200 study subjects were interviewed with the help of a semi-structured questionnaire. The study findings were recorded and analyzed using SPSS version 20. Results: Out of 200 subjects, most 95 (47.5%) of subjects belonged to the age group between 40 to 60 and 109 (54.5%) were females and 91 (45.5%) were male. Majority of the participants were medical students; 62 (31%) followed by paramedical staff; 49 (24.5%), laborers and doctors; 26 (13%). Only 88 (44%) participants had heard about cough etiquette. Most common source of information regarding the proper cough and sneeze etiquette among the participants was television or internet;112 (61%). The patients and their attendants were having poor knowledge regarding the proper cough and sneeze etiquette. Conclusions: The knowledge and practice of cough and sneezing etiquette was not satisfactory especially among the general population. There is the utmost need for awareness regarding the knowledge and correct practice of cough etiquette.
- 30 November 2023
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 10  (12) , 4712-4717
Open AccessA descriptive study to assess the knowledge and practices related to cough and sneeze etiquette among health care providers, respiratory patients and their attendants in a tertiary care centre
Background: The emergence of respiratory infections including Tuberculosis, COVID-19, influenza A and B viruses have a significant impact on health worldwide. Cough and sneezing etiquette including respiratory hygiene have been recommended as most cost-effective preventative tool to reduce such transmission. Methods: A cross-sectional descriptive study was conducted among health care providers, respiratory patients and their attendants admitted in the Respiratory Medicine department at a tertiary care hospital for 6 months duration i.e., from December 2022 to May 2023, aiming to assess the knowledge and practices related to cough and sneeze etiquette. A total of 200 study subjects were interviewed with the help of a semi-structured questionnaire. The study findings were recorded and analyzed using SPSS version 20. Results: Out of 200 subjects, most 95 (47.5%) of subjects belonged to the age group between 40 to 60 and 109 (54.5%) were females and 91 (45.5%) were male. Majority of the participants were medical students; 62 (31%) followed by paramedical staff; 49 (24.5%), laborers and doctors; 26 (13%). Only 88 (44%) participants had heard about cough etiquette. Most common source of information regarding the proper cough and sneeze etiquette among the participants was television or internet;112 (61%). The patients and their attendants were having poor knowledge regarding the proper cough and sneeze etiquette. Conclusions: The knowledge and practice of cough and sneezing etiquette was not satisfactory especially among the general population. There is the utmost need for awareness regarding the knowledge and correct practice of cough etiquette.